Orthopedic management of patients with pompe disease: A retrospective case series of 8 patients

The Scientific World Journal

Volumn 2014, Issue , 2014, Pages

  Haaker, Gerrit ^a   Forst, Jürgen ^a   Forst, Raimund ^a   Fujak, Albert ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BODY POSTURE; CASE STUDY; CHILD; CLINICAL ARTICLE; CONSULTATION; FEMALE; FEMUR FRACTURE; FOOT MALFORMATION; GLYCOGEN STORAGE DISEASE TYPE 2; HIP CONTRACTURE; HIP DYSPLASIA; HIP SURGERY; HUMAN; KNEE DISEASE; LIMB WEAKNESS; MALE; MIDDLE AGED; MUSCULOSKELETAL DISEASE; NEUROMUSCULAR DISEASE; ORTHOPEDIC SURGERY; PEDICLE SCREW; PHYSIOTHERAPY; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SCHOOL CHILD; SCOLIOSIS; SHOULDER DISLOCATION; SITTING; SPINE FIXATION DEVICE; SPINE STABILIZATION; YOUNG ADULT; CASE REPORT; FRACTURE; RADIOGRAPHY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; FRACTURES, BONE; GLYCOGEN STORAGE DISEASE TYPE II; HUMANS; MALE; MIDDLE AGED; MUSCULOSKELETAL DISEASES; ORTHOPEDIC PROCEDURES; SCOLIOSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84893206138     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2014/963861     Document Type: Article

References (28)

1. Cupler E. J., Berger K. I., Leshner R. T., Wolfe G. I., Han J. J., Barohn R. J., Kissel J. T., Consensus treatment recommendations for late-onset pompe disease. Muscle and Nerve 2012 45 3 319 333 2-s2.0-84857066318 10.1002/mus.22329
2. Kishnani P. S., Beckemeyer A. A., Mendelsohn N. J., The new era of Pompe disease: advances in the detection, understanding of the phenotypic spectrum, pathophysiology, and management. American Journal of Medical Genetics C 2012 160 1 1 7 2-s2.0-84856227172 10.1002/ajmg.c.31324
3. Ausems M. G., Verbiest J., Hermans M. M. P., Kroos M. A., Beemer F. A., Wokke J. H. J., Sandkuijl L. A., Reuser A. J. J., Van Der Ploeg A. T., Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counselling. European Journal of Human Genetics 1999 7 6 713 716 2-s2.0-0032848015 10.1038/sj.ejhg.5200367 (Pubitemid 29424063)
4. Kishnani P. S., Hwu W.-L., Mandel H., Nicolino M., Yong F., Corzo D., Infantile-onset Pompe disease natural history study G: a retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease. The Journal of Pediatrics 2006 148 5 671 676 2-s2.0-33646830132 10.1016/j.jpeds.2005.11.033 (Pubitemid 43776899)
5. Kishnani P. S., Steiner R. D., Bali D., Berger K., Byrne B. J., Case L., Crowley J. F., Downs S., Howell R. R., Kravitz R. M., Mackey J., Marsden D., Martins A. M., Millington D. S., Nicolino M., O'Grady G., Patterson M. C., Rapoport D. M., Slonim A., Spencer C. T., Tifft C. J., Watson M. S., Pompe disease diagnosis and management guideline. Genetics in Medicine 2006 8 5 267 288 2-s2.0-33745589302 10.1097/01.gim.0000218152.87434.f3 (Pubitemid 44297314)
6. Kishnani P. S., Howell R. R., Pompe disease in infants and children. The Journal of Pediatrics 2004 144 5 S35 S43 2-s2.0-2342537868 10.1016/j.jpeds.2004. 01.053 (Pubitemid 38591273)
7. van der Ploeg A. T., Clemens P. R., Corzo D., Escolar D. M., Florence J., Groeneveld G. J., Herson S., Kishnani P. S., Laforet P., Lake S. L., Lange D. J., Leshner R. T., Mayhew J. E., Morgan C., Nozaki K., Park D. J., Pestronk A., Rosenbloom B., Skrinar A., van Capelle C. I., van der Beek N. A., Wasserstein M., Zivkovic S. A., A randomized study of alglucosidase alfa in late-onset Pompe's disease. The New England Journal of Medicine 2010 362 15 1396 1406 2-s2.0-77950963839 10.1056/NEJMoa0909859
8. Kishnani P. S., Corzo D., Leslie N. D., Gruskin D., Van Der Ploeg A., Clancy J. P., Parini R., Morin G., Beck M., Bauer M. S., Jokic M., Tsai C.-E., Tsai B. W. H., Morgan C., O'Meara T., Richards S., Tsao E. C., Mandel H., Early treatment with alglucosidase alfa prolongs long-term survival of infants with pompe disease. Pediatric Research 2009 66 3 329 335 2-s2.0-70350448214 10.1203/PDR.0b013e3181b24e94
9. Angelini C., Semplicini C., Ravaglia S., Bembi B., Servidei S., Pegoraro E., Moggio M., Filosto M., Sette E., Crescimanno G., Tonin P., Parini R., Morandi L., Marrosu G., Greco G., Musumeci O., Di Iorio G., Siciliano G., Donati M. A., Carubbi F., Ermani M., Mongini T., Toscano A., Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years. Journal of Neurology 2011 259 5 952 958 2-s2.0-80755141323 10.1007/s00415-011-6293-5
10. Nicolino M., Byrne B., Wraith J. E., Leslie N., Mandel H., Freyer D. R., Arnold G. L., Pivnick E. K., Ottinger C. J., Robinson P. H., Loo J.-C. A., Smitka M., Jardine P., Tatò L., Chabrol B., McCandless S., Kimura S., Mehta L., Bali D., Skrinar A., Morgan C., Rangachari L., Corzo D., Kishnani P. S., Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease. Genetics in Medicine 2009 11 3 210 219 2-s2.0-63449127241 10.1097/GIM.0b013e31819d0996
11. Gungor D., Kruijshaar M. E., Plug I., Agostino RB D., Sr, Hagemans M. L., van Doorn P. A., Reuser A. J., van der Ploeg A. T., Impact of enzyme replacement therapy on survival in adults with Pompe disease: results from a prospective international observational study. Orphanet Journal of Rare Diseases 2013 8 49 10.1186/1750-1172-8-49
12. van der Ploeg A. T., Reuser A. J., Pompe's disease. The Lancet 2008 372 9646 1342 1353 2-s2.0-53449093327 10.1016/S0140-6736(08)61555-X
13. Case L. E., Beckemeyer A. A., Kishnani P. S., Infantile Pompe disease on ERT: update on clinical presentation, musculoskeletal management, and exercise considerations. American Journal of Medical Genetics C 2012 160 1 69 79 2-s2.0-84856223173 10.1002/ajmg.c.31321
14. Case L. E., Kishnani P. S., Physical therapy management of Pompe disease. Genetics in Medicine 2006 8 5 318 327 2-s2.0-33745625409 10.1097/01.gim. 0000217789.14470.c5 (Pubitemid 44297320)
15. Roberts M., Kishnani P. S., van der Ploeg A. T., Müller-Felber W., Merlini L., Prasad S., Case L. E., The prevalence and impact of scoliosis in Pompe disease: lessons learned from the Pompe registry. Molecular Genetics and Metabolism 2011 104 4 574 582 2-s2.0-82255191641 10.1016/j.ymgme.2011.08.011
16. Hagemans M. L. C., Winkel L. P. F., van Doorn P. A., Hop W. J. C., Loonen M. C. B., Reuser A. J. J., van der Ploeg A. T., Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients. Brain 2005 128 3 671 677 2-s2.0-15044356217 10.1093/brain/awh384 (Pubitemid 40380201)
17. Favejee M. M., Huisstede B. M., Bussmann J. B., Kruijshaar M. E., van der Ploeg A. T., Physiotherapy management in late-onset Pompe disease: clinical practice in 88 patients. Molecular Genetics and Metabolism 2012 107 111 115 10.1016/j.ymgme.2012.07.014
18. Case L. E., Hanna R., Frush D. P., Krishnamurthy V., DeArmey S., Mackey J., Boney A., Morgan C., Corzo D., Bouchard S., Weber T. J., Chen Y.-T., Kishnani P. S., Fractures in children with Pompe disease: a potential long-term complication. Pediatric Radiology 2007 37 5 437 445 2-s2.0-34147184428 10.1007/s00247-007-0428-y (Pubitemid 46567092)
19. van den Berg L. E. M., Zandbergen A. A., van Capelle C. I., de Vries J. M., Hop W. C., van den Hout J. M., Reuser A. J. J., Zillikens M. C., van der Ploeg A. T., Low bone mass in Pompe disease: muscular strength as a predictor of bone mineral density. Bone 2010 47 3 643 649 2-s2.0-77955842384 10.1016/j.bone.2010.06.021
20. Papadimas G., Terzis G., Papadopoulos C., Areovimata A., Spengos K., Kavouras S., Manta P., Bone density in patients with late onset Pompe disease. International Journal of Endocrinology and Metabolism 2012 10 599 603 10.5812/ijem.4967
21. Ing R. J., Cook D. R., Bengur R. A., Williams E. A., Eck J., Dear G. D. L., Ross A. K., Kern F. H., Kishnani P. S., Anaesthetic management of infants with glycogen storage disease type II: a physiological approach. Paediatric Anaesthesia 2004 14 6 514 519 2-s2.0-2942548954 10.1111/j.1460-9592.2004.01242.x (Pubitemid 38758675)
22. Fadic R., Waclawik A. J., Brooks B. R., Lotz B. P., The rigid spine syndrome due to acid maltase deficiency. Muscle & Nerve 1997 20 364 366 (Pubitemid 27108157)
23. Kostera-Pruszczyk A., Opuchlik A., Ługowska A., Nadaj A., Bojakowski J., Tylki-Szymanska A., Kaminska A., Juvenile onset acid maltase deficiency presenting as a rigid spine syndrome. Neuromuscular Disorders 2006 16 4 282 285 2-s2.0-33645976485 10.1016/j.nmd.2006.02.001
24. Laforêt P., Doppler V., Caillaud C., Laloui K., Claeys K. G., Richard P., Ferreiro A., Eymard B., Rigid spine syndrome revealing late-onset Pompe disease. Neuromuscular Disorders 2010 20 2 128 130 2-s2.0-75549084616 10.1016/j.nmd.2009.11.006
25. Prater S. N., Patel T. T., Buckley A. F., Mandel H., Vlodavski E., Banugaria S. G., Feeney E. J., Raben N., Kishnani P. S., Skeletal muscle pathology of infantile Pompe disease during long-term enzyme replacement therapy. Orphanet Journal of Rare Diseases 2013 8 90 10.1186/1750-1172-8-90
26. Prater S. N., Banugaria S. G., DeArmey S. M., Botha E. G., Stege E. M., Case L. E., Jones H. N., Phornphutkul C., Wang R. Y., Young S. P., Kishnani P. S., The emerging phenotype of long-term survivors with infantile Pompe disease. Genetics in Medicine 2012 14 800 810 10.1038/gim.2012.44
27. Jones H. N., Moss T., Edwards L., Kishnani P. S., Increased inspiratory and expiratory muscle strength following respiratory muscle strength training (RMST) in two patients with late-onset Pompe disease. Molecular Genetics and Metabolism 2011 104 3 417 420 2-s2.0-82455188056 10.1016/j.ymgme.2011.05.006
28. Ambrosino N., Confalonieri M., Crescimanno G., Vianello A., Vitacca M., The role of respiratory management of Pompe disease. Respiratory Medicine 2013 107 1124 1132 10.1016/j.rmed.2013.03.004